Guarantor Disclosures | Guarantor Disclosures The Company's payment obligations under the 3.60% senior notes due 2022 , the 3.60% 2026 Senior Notes, the 5.0% 2046 Senior Notes, 4.625% Westlake 2021 Senior Notes and the 4.875% Westlake 2023 Senior Notes are fully and unconditionally guaranteed by each of its current and future domestic subsidiaries that guarantee other debt of the Company or of another guarantor of those notes in excess of $5,000 (the "Guarantor Subsidiaries"). Each Guarantor Subsidiary is 100% owned by Westlake Chemical Corporation (the " 100% Owned Guarantor Subsidiaries"). In October 2016, the Company executed a Joinder Agreement with the Administrative Agent of the Credit Agreement, whereby certain subsidiaries of the Company were added as Guarantor Subsidiaries. These guarantees are the joint and several obligations of the Guarantor Subsidiaries. The following unaudited condensed consolidating financial information presents the financial condition, results of operations and cash flows of Westlake Chemical Corporation, the 100% owned Guarantor Subsidiaries, and the remaining subsidiaries that do not guarantee the 3.60% senior notes due 2022 , the 3.60% 2026 Senior Notes, the 5.0% 2046 Senior Notes, 4.625% Westlake 2021 Senior Notes and the 4.875% Westlake 2023 Senior Notes (the "Non-Guarantor Subsidiaries"), together with consolidating eliminations necessary to present the Company's results on a consolidated basis. In August 2016, certain of the Company's subsidiary guarantors were released from their guarantees of the Company's 3.60% senior notes due 2022 in connection with the replacement of the Company's revolving credit facility. Westlake Chemical OpCo LP, which was previously separately presented as a less than 100% owned guarantor, and certain of the Company's other 100% owned subsidiaries that were previously presented as guarantors, are now reflected as Non-Guarantor Subsidiaries in the condensed consolidating guarantor financial information. Prior periods were retrospectively adjusted to conform to the current presentation of Guarantor Subsidiaries and Non-Guarantor Subsidiaries. Condensed Consolidating Financial Information as of June 30, 2017 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Balance Sheet Current assets Cash and cash equivalents $ 49,366 $ 15,399 $ 331,011 $ — $ 395,776 Accounts receivable, net 2,742,556 3,785,141 364,318 (5,796,207 ) 1,095,808 Inventories — 631,802 199,898 — 831,700 Prepaid expenses and other current assets 75,730 40,213 9,349 (79,548 ) 45,744 Restricted cash — 1,500 7,107 — 8,607 Total current assets 2,867,652 4,474,055 911,683 (5,875,755 ) 2,377,635 Property, plant and equipment, net — 4,326,202 1,990,529 — 6,316,731 Other assets, net Goodwill — 847,816 151,798 — 999,614 Customer relationships, net — 509,933 144,159 — 654,092 Other intangible assets, net — 97,224 72,767 — 169,991 Deferred charges and other assets, net 9,552,799 790,393 1,540,773 (11,516,321 ) 367,644 Total other assets, net 9,552,799 2,245,366 1,909,497 (11,516,321 ) 2,191,341 Total assets $ 12,420,451 $ 11,045,623 $ 4,811,709 $ (17,392,076 ) $ 10,885,707 Current liabilities Accounts payable $ 5,183,033 $ 815,642 $ 343,531 $ (5,758,697 ) $ 583,509 Accrued liabilities — 355,132 209,338 (117,058 ) 447,412 Total current liabilities 5,183,033 1,170,774 552,869 (5,875,755 ) 1,030,921 Long-term debt, net 3,396,581 4,537,551 421,405 (4,865,637 ) 3,489,900 Deferred income taxes — 1,573,733 97,781 (22,985 ) 1,648,529 Pension and other liabilities — 365,170 142,144 — 507,314 Total liabilities 8,579,614 7,647,228 1,214,199 (10,764,377 ) 6,676,664 Total Westlake Chemical Corporation stockholders' equity 3,840,837 3,398,395 3,229,304 (6,627,699 ) 3,840,837 Noncontrolling interests — — 368,206 — 368,206 Total equity 3,840,837 3,398,395 3,597,510 (6,627,699 ) 4,209,043 Total liabilities and equity $ 12,420,451 $ 11,045,623 $ 4,811,709 $ (17,392,076 ) $ 10,885,707 Condensed Consolidating Financial Information as of December 31, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated Balance Sheet Current assets Cash and cash equivalents $ 146,990 $ 53,006 $ 259,457 $ — $ 459,453 Accounts receivable, net 2,117,540 3,329,871 323,931 (4,832,599 ) 938,743 Inventories — 597,819 203,281 — 801,100 Prepaid expenses and other current assets 30,748 41,755 12,494 (36,504 ) 48,493 Restricted cash — — 160,527 — 160,527 Total current assets 2,295,278 4,022,451 959,690 (4,869,103 ) 2,408,316 Property, plant and equipment, net — 4,475,943 1,944,119 — 6,420,062 Other assets, net Goodwill — 791,706 154,847 — 946,553 Customer relationships, net — 468,645 142,970 — 611,615 Other intangible assets, net — 130,243 71,177 (25,581 ) 175,839 Deferred charges and other assets, net 9,170,042 874,003 1,115,877 (10,832,054 ) 327,868 Total other assets, net 9,170,042 2,264,597 1,484,871 (10,857,635 ) 2,061,875 Total assets $ 11,465,320 $ 10,762,991 $ 4,388,680 $ (15,726,738 ) $ 10,890,253 Current liabilities Accounts payable $ 4,330,375 $ 748,364 $ 225,300 $ (4,807,780 ) $ 496,259 Accrued liabilities 26,367 389,216 183,223 (61,323 ) 537,483 Term loan — — 149,341 — 149,341 Total current liabilities 4,356,742 1,137,580 557,864 (4,869,103 ) 1,183,083 Long-term debt, net 3,584,949 4,090,775 — (3,997,070 ) 3,678,654 Deferred income taxes — 1,581,260 91,809 (22,494 ) 1,650,575 Pension and other liabilities — 360,622 125,274 — 485,896 Total liabilities 7,941,691 7,170,237 774,947 (8,888,667 ) 6,998,208 Total Westlake Chemical Corporation stockholders' equity 3,523,629 3,592,754 3,245,317 (6,838,071 ) 3,523,629 Noncontrolling interests — — 368,416 — 368,416 Total equity 3,523,629 3,592,754 3,613,733 (6,838,071 ) 3,892,045 Total liabilities and equity $ 11,465,320 $ 10,762,991 $ 4,388,680 $ (15,726,738 ) $ 10,890,253 Condensed Consolidating Financial Information for the Three Months Ended June 30, 2017 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 1,596,952 $ 804,002 $ (421,793 ) $ 1,979,161 Cost of sales — 1,346,983 641,349 (415,005 ) 1,573,327 Gross profit — 249,969 162,653 (6,788 ) 405,834 Selling, general and administrative expenses 142 95,845 41,427 (6,788 ) 130,626 Transaction and integration-related costs — 8,092 — — 8,092 Income (loss) from operations (142 ) 146,032 121,226 — 267,116 Other income (expense) Interest expense (38,160 ) (45,783 ) (34 ) 45,005 (38,972 ) Other income (expense), net 37,282 3,550 3,635 (45,005 ) (538 ) Income (loss) before income taxes (1,020 ) 103,799 124,827 — 227,606 Provision for (benefit from) income taxes 4,616 52,083 11,489 — 68,188 Equity in net income of subsidiaries 158,463 — — (158,463 ) — Net income 152,827 51,716 113,338 (158,463 ) 159,418 Net income attributable to noncontrolling interests — — 6,591 — 6,591 Net income attributable to Westlake Chemical Corporation $ 152,827 $ 51,716 $ 106,747 $ (158,463 ) $ 152,827 Comprehensive income attributable to Westlake Chemical Corporation $ 203,090 $ 51,776 $ 148,417 $ (200,193 ) $ 203,090 Condensed Consolidating Financial Information for the Three Months Ended June 30, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 820,190 $ 553,173 $ (287,302 ) $ 1,086,061 Cost of sales — 698,096 428,898 (282,299 ) 844,695 Gross profit — 122,094 124,275 (5,003 ) 241,366 Selling, general and administrative expenses 950 44,020 21,461 (5,003 ) 61,428 Income (loss) from operations (950 ) 78,074 102,814 — 179,938 Other income (expense) Interest expense (11,151 ) (5,686 ) (205 ) 11,127 (5,915 ) Other income (expense), net 4,050 (1,183 ) 16,441 (11,127 ) 8,181 Income (loss) before income taxes (8,051 ) 71,205 119,050 — 182,204 Provision for (benefit from) income taxes (2,960 ) 55,671 13,873 — 66,584 Equity in net income of subsidiaries 116,215 — — (116,215 ) — Net income 111,124 15,534 105,177 (116,215 ) 115,620 Net income attributable to noncontrolling interests — — 4,496 — 4,496 Net income attributable to Westlake Chemical Corporation $ 111,124 $ 15,534 $ 100,681 $ (116,215 ) $ 111,124 Comprehensive income attributable to Westlake Chemical Corporation $ 119,686 $ 15,634 $ 102,296 $ (117,930 ) $ 119,686 Condensed Consolidating Financial Information for the Six Months Ended June 30, 2017 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 3,176,677 $ 1,540,087 $ (794,987 ) $ 3,921,777 Cost of sales — 2,706,258 1,224,009 (781,467 ) 3,148,800 Gross profit — 470,419 316,078 (13,520 ) 772,977 Selling, general and administrative expenses 919 188,109 78,769 (13,520 ) 254,277 Transaction and integration-related costs — 16,224 62 — 16,286 Income (loss) from operations (919 ) 266,086 237,247 — 502,414 Other income (expense) Interest expense (76,345 ) (91,460 ) (840 ) 89,897 (78,748 ) Other income (expense), net 74,439 3,293 16,698 (89,897 ) 4,533 Income (loss) before income taxes (2,825 ) 177,919 253,105 — 428,199 Provision for (benefit from) income taxes (851 ) 105,455 19,467 — 124,071 Equity in net income of subsidiaries 292,991 — — (292,991 ) — Net income 291,017 72,464 233,638 (292,991 ) 304,128 Net income attributable to noncontrolling interests — — 13,111 — 13,111 Net income attributable to Westlake Chemical Corporation $ 291,017 $ 72,464 $ 220,527 $ (292,991 ) $ 291,017 Comprehensive income attributable to Westlake Chemical Corporation $ 355,787 $ 72,449 $ 259,034 $ (331,483 ) $ 355,787 Condensed Consolidating Financial Information for the Six Months Ended June 30, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 1,581,931 $ 1,122,992 $ (643,675 ) $ 2,061,248 Cost of sales — 1,340,833 856,668 (633,204 ) 1,564,297 Gross profit — 241,098 266,324 (10,471 ) 496,951 Selling, general and administrative expenses 1,557 81,017 42,634 (10,471 ) 114,737 Income (loss) from operations (1,557 ) 160,081 223,690 — 382,214 Other income (expense) Interest expense (21,563 ) (12,471 ) (459 ) 21,893 (12,600 ) Other income (expense), net 5,865 (75 ) 26,929 (21,893 ) 10,826 Income (loss) before income taxes (17,255 ) 147,535 250,160 — 380,440 Provision for (benefit from) income taxes (6,182 ) 117,874 24,192 — 135,884 Equity in net income of subsidiaries 245,325 — — (245,325 ) — Net income 234,252 29,661 225,968 (245,325 ) 244,556 Net income attributable to noncontrolling interests — — 10,304 — 10,304 Net income attributable to Westlake Chemical Corporation $ 234,252 $ 29,661 $ 215,664 $ (245,325 ) $ 234,252 Comprehensive income attributable to Westlake Chemical Corporation $ 281,443 $ 29,967 $ 254,514 $ (284,481 ) $ 281,443 Condensed Consolidating Financial Information for the Six Months Ended June 30, 2017 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Cash Flows Cash flows from operating activities Net income $ 291,017 $ 72,464 $ 233,638 $ (292,991 ) $ 304,128 Adjustments to reconcile net income to net cash provided by (used for) operating activities Depreciation and amortization — 193,594 101,305 — 294,899 Deferred income taxes (126 ) 15,207 (119 ) — 14,962 Net changes in working capital and other (400,511 ) (25,601 ) (1,154 ) 292,991 (134,275 ) Net cash provided by (used for) operating activities (109,620 ) 255,664 333,670 — 479,714 Cash flows from investing activities Additions to property, plant and equipment — (198,621 ) (82,281 ) — (280,902 ) Additions to cost method investment — (31,000 ) — — (31,000 ) Proceeds from disposition of assets — 3 130 — 133 Proceeds from involuntary conversion of assets — 1,672 — — 1,672 Settlements of derivative instruments — (376 ) — — (376 ) Net cash used for investing activities — (228,322 ) (82,151 ) — (310,473 ) Cash flows from financing activities Intercompany financing 241,210 (253,075 ) 11,865 — — Dividends paid (49,315 ) — — — (49,315 ) Distributions to noncontrolling interests — 188,646 (204,679 ) — (16,033 ) Proceeds from issuance of notes payable — — 3,544 — 3,544 Proceeds from drawdown of revolver 175,000 — — — 175,000 Restricted cash associated with term loan 154,000 — — — 154,000 Repayment of term loan (150,000 ) — — — (150,000 ) Repayment of notes payable — (520 ) (4,381 ) — (4,901 ) Repayment of revolver (360,000 ) — — — (360,000 ) Other, net 1,101 — — — 1,101 Net cash provided by (used for) financing activities 11,996 (64,949 ) (193,651 ) — (246,604 ) Effect of exchange rate changes on cash and cash equivalents — — 13,686 — 13,686 Net increase (decrease) in cash and cash equivalents (97,624 ) (37,607 ) 71,554 — (63,677 ) Cash and cash equivalents at beginning of period 146,990 53,006 259,457 — 459,453 Cash and cash equivalents at end of period $ 49,366 $ 15,399 $ 331,011 $ — $ 395,776 Condensed Consolidating Financial Information for the Six Months Ended June 30, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Cash Flows Cash flows from operating activities Net income $ 234,252 $ 29,661 $ 225,968 $ (245,325 ) $ 244,556 Adjustments to reconcile net income to net cash provided by operating activities Depreciation and amortization — 66,137 66,827 — 132,964 Deferred income taxes (4,802 ) 96,990 10,802 — 102,990 Net changes in working capital and other (274,585 ) (38,234 ) (43,124 ) 245,325 (110,618 ) Net cash provided by (used for) operating activities (45,135 ) 154,554 260,473 — 369,892 Cash flows from investing activities Additions to property, plant and equipment — (94,775 ) (192,385 ) — (287,160 ) Proceeds from disposition of assets — 7 98 — 105 Proceeds from sales and maturities of securities 302,432 — — — 302,432 Purchase of securities (130,830 ) (7,592 ) — — (138,422 ) Settlements of derivative instruments — (3,372 ) — — (3,372 ) Net cash provided by (used for) investing activities 171,602 (105,732 ) (192,287 ) — (126,417 ) Cash flows from financing activities Intercompany financing 106,904 (212,948 ) 106,044 — — Debt issuance costs (9,700 ) — — — (9,700 ) Dividends paid (47,317 ) — — — (47,317 ) Distributions to noncontrolling interests — 158,392 (166,476 ) — (8,084 ) Proceeds from issuance of notes payable — — 3,842 — 3,842 Repayment of notes payable — — (8,626 ) — (8,626 ) Repurchase of common stock for treasury (67,404 ) — — — (67,404 ) Other 800 — — — 800 Net cash used for financing activities (16,717 ) (54,556 ) (65,216 ) — (136,489 ) Effect of exchange rate changes on cash and cash equivalents — — 1,486 1,486 Net increase (decrease) in cash and cash equivalents 109,750 (5,734 ) 4,456 — 108,472 Cash and cash equivalents at beginning of period 303,131 6,818 352,576 — 662,525 Cash and cash equivalents at end of period $ 412,881 $ 1,084 $ 357,032 $ — $ 770,997 |